GP Resources
​Co Prescribing Hepatitis C Medications
 
With the availability of new Hepatitis C medications on the Pharmaceutical Benefits Scheme (PBS), affordable treatment possibilities have opened up for those living with Hepatitis C.  
 
If you have patients with Hepatitis C please contact me so I can offer consultative assistance and a co-prescribing service for these patients.
Hepatitis C Referral Pathway
The Royal Hobart Hospital (RHH)
Hepatitis C page:
click here
To review the Hepatitis C referral pathway through the Tasmanian Health Service: 
click here
REFERRAL FORM:
click here
Please provide
  • Estimated duration of HCV infection

  • Previous HCV treatment experience e.g. date, regimen and response

  • Co factors for liver disease progression:

    • alcohol intake 

    • marijuana use

    • virological cofactors (HIV, HBV)

    • diabetes 

    • obesity

  • Current and past renal disease

  • Ischaemic heart disease or cardiovascular risk factors

  • Vaccinations history especially for Hepatitis A and B

  • Physical and psychiatric comorbidities

  • Ongoing risk factors for viral transmission and reinfection

  • Social issues such as potential barriers to medication adherence

  • Concomitant medications including prescription, over-the-counter and illicit drug use

Examination

  • Features of cirrhosis such as hard liver edge, spider naevi, leukonychia

  • Features of decompensation or portal hypertension, e.g. jaundice, ascites, oedema, bruising, muscle wasting, encephalopathy

  • Weight and BMI

For Patients with Irritable Bowel Syndrome (IBS) Symptoms 
e.g. alternating diarrhoea and constipation, abdominal bloating and/or pain, flatus
 
You may like to consider a low FODMAP diet for your patients with suspected IBS as this has shown to be effective in the majority of IBS patients.  Feel free to contact me to discuss or refer for review.  
 
Clcik here to read more on the low FODMAP diet 
EMERGENCY CONDITIONS / SYMPTOMS 

- Upper gastrointestinal tract haemorrhage (e.g. haematemesis and/or melaena)

- Suspected bowel obstruction (vomiting and distension with constipation) 

- Suspected acute, severe or fulminant hepatic failure.  

 

For more information click here

For private patients requiring non-urgent review or management please liaise with me on (03) 6228 0291 or for public patients on (03) 6166 8308
Colonoscopy Referral for Public Patients
 
The current wait list times for those patients who wish to access services through the Royal Hobart Hospital (RHH) can be substantial.  See here for the latest estimated wait times
Click here for Gastroenterology patient referral information. 

All patients referred for surveillance colonoscopies after removal of polyps or for family history are triaged according to family history, surveillance of colonic polyps and bowel cancer

All referrals are triaged and appointments are provided based on clinical priority. Some patients may be suitable for direct access endoscopy – if this is the case you will receive notification from the Endoscopy Booking Office that your patient has been placed on the Endoscopy Waiting List. 

Endoscopy Waiting List

If you have a patient currently waiting on the Endoscopy Waiting List and you wish to discuss their current waiting time or have concerns re their clinical status please contact: Endoscopy Liaison Coordinator  Phone: (03) 6222 8367 during business hours

 

For other endoscopy enquires please phone (03) 6222 8605 during business hours

Hepatitis C Resources
To access the latest information from GESA 
 
click here
PUBLICATION
 
Severe contact Esophagitis in a patient taking Crizotinib: A case report.  
This is a case study I co-authored with Colleagues from the Royal Hobart Hospital for the Asia-Pacific Journal of Clinical Oncology 2015
 
  • LinkedIn Social Icon